Participants from 32 countries, representing approximately 350 companies, attended DVCon U.S. 2025, including 404 first-time attendees. The event featured 32 sponsors and exhibitors, six of whom were ...

Lunit to present 15 studies, with an unprecedented 13 accepted as oral presentations, marking a significant milestone in AI-powered radiology research Key studies demonstrate AI's capability to ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...

Details of the presentation are as follows ... of genetic medicines to treat diseases at their root cause with oral small molecule medicines that have benefits of systemic biodistribution ...

Late-breaking oral presentation to highlight 52-week data of ESK-001 in a Phase 2 open-label extension (OLE) study in adults with moderate-to-severe plaque psoriasis – ...

The 2025 Stuart Sutherland Best Oral Presentation and Best Poster winners, as voted on by attendees, were announced during a reception in the exhibit hall on February 26. Participants from 32 ...